The European Innovation Council is the European Union’s flagship deep-tech innovation program, based in Brussels, and designed to fund high-risk, high-impact technologies. It combines non-dilutive grants with direct equity investment through a blended finance model, making it unusually powerful for early-stage scientific ventures.

The EIC has backed a large number of deep-tech companies across Europe, including startups relevant to neurotechnology, neurorehabilitation, and advanced medical devices. Its role as a cornerstone investor often helps attract additional private capital and gives companies an important validation signal.

Its geographic scope covers the European Union and associated countries. For neurotech founders in Europe, the EIC is one of the most important public funding mechanisms available for bridging the gap between breakthrough science and venture readiness.